This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and protecting public health in the midst of COVID-19.

In-kind contributions provide services to nonprofits like the Sabin Vaccine Institute (Sabin) that would otherwise be unaffordable, freeing up scarce resources to be spent on our core mission – expanding the benefits of immunization around the world.

Over the course of the past year, the COVID-19 pandemic has repeatedly demonstrated its ability to exploit preexisting inequities.

The vaccine research and development (R&D) ecosystem has yielded life-saving products for decades by leveraging innovation, collaboration, and partnership; but the rapid development of COVID-19 vaccines illustrated that even more is possible when the right circumstances are in place to catalyze progress.